Responses of Airway Epithelium to Environmental Injury: Role in the Induction Phase of Childhood Asthma by Kumar, Rakesh K. et al.
Hindawi Publishing Corporation
Journal of Allergy
Volume 2011, Article ID 257017, 7 pages
doi:10.1155/2011/257017
Review Article
Responsesof Airway Epitheliumto Environmental Injury:
Role in the Induction Phase of ChildhoodAsthma
RakeshK. Kumar,1 JessicaS.Siegle,1 GerardE.Kaiko,2 CristanHerbert,1
Joerg E. Mattes,2 andPaulS.Foster2
1Inﬂammation and Infection Research Centre, School of Medial Sciences, University of New South Wales, Sydney, NSW 2052, Australia
2Centre for Asthma and Respiratory Disease, School of Biomedical Sciences,
University of Newcastle and Hunter Medical Research Institute, Callaghan, NSW 2300, Australia
Correspondence should be addressed to Rakesh K. Kumar, r.kumar@unsw.edu.au
Received 9 May 2011; Accepted 26 August 2011
Academic Editor: Teal S. Hallstrand
Copyright © 2011 Rakesh K. Kumar et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
The pathogenesis of allergic asthma in childhood remains poorly understood. Environmental factors which appear to contribute
to allergic sensitisation, with development of a Th2-biased immunological response in genetically predisposed individuals, include
wheezing lower respiratory viral infections in early life and exposure to airborne environmental pollutants. These may activate
pattern recognition receptors and/or cause oxidant injury to airway epithelial cells (AECs). In turn, this may promote Th2
polarisation via a “ﬁnal common pathway” involving interaction between AEC, dendritic cells, and CD4+ T lymphocytes.
Potentially important cytokines produced by AEC include thymic stromal lymphopoietin and interleukin-25. Their role is
supported by in vitro studies using human AEC, as well as by experiments in animal models. To date, however, few investigations
have employed models of the induction phase of childhood asthma. Further research may help to identify interventions that could
reduce the risk of allergic asthma.
1.Introduction
Asthmaisoneofthemostcommonchronicdiseasesaffecting
children, especially in economically developed nations. For
example, in Australia the prevalence of current asthma in
children aged 0–15 years is approximately 11% [1]. Child-
hood asthma is strongly linked to atopy, which in turn
is characteristically associated with a Th2-biased immuno-
logical response [2–4]. While this relationship is well doc-
umented, the pathogenesis of childhood asthma remains
largely unexplained.
However, it is clear that both genetic predisposition and
a variety of environmental factors contribute to the devel-
opment of allergic asthma [4]. Notable among the environ-
mental factors that appear to be crucial in the induction
of disease is respiratory viral infection, in particular with
rhinovirus (RV) or respiratory syncytial virus (RSV). The
association between childhood infections and asthma is
complex, because at least in some settings, repeated early-
life exposure to infectious agents may reduce the likelihood
of developing allergic diseases [5]. Despite this, epidemio-
logical studies strongly suggest that lower respiratory viral
infections associated with wheezing, occurring within a
critical period of development in early childhood, play an
important role in the subsequent development of asthma in
children who are repeatedly exposed to inhaled allergens [6–
10].
Another clearly deﬁned risk factor for childhood allergic
asthma is early-life exposure to airborne environmental irri-
tants. The importance of exposure to environmental tobacco
smokeiswellestablished[11,12].Morerecently,anumberof
large population-based studies, including prospective cohort
studies, have clearly deﬁned the increased risk of develop-
ment of asthma in children exposed to traﬃc-related partic-
ulate pollutants [13–15]. The adverse respiratory eﬀects of
suchpollutants,especiallydieselexhaustparticulates(DEPs),2 Journal of Allergy
are now recognised as a signiﬁcant public health problem
[16].
Somewhat more contentious is the association between
the use of paracetamol (acetaminophen) in infancy or
childhood and the subsequent development of asthma [17,
18]. The evidence for an increased risk of asthma following
exposures to other environmental chemicals is much less
convincing [19].
Fundamental questions remain unanswered about the
underlyingmechanismsbywhichenvironmentalfactorspro-
mote the development of childhood asthma. In particular, if
atopy and a Th2-biased immunological response are indeed
precursors to the development of childhood asthma, a key
issue is how does injury by environmental factors drive an
allergic response?
A possible “ﬁnal common pathway,” for which there
is now growing support, is based on the interaction be-
tween airway epithelial cells, dendritic cells, and CD4+ T-
lymphocytes.
2. DrivingaTh2-Biased
ImmunologicalResponse
Dendritic cells (DCs) have long been recognised as playing
a crucial role in the induction of Th2 polarisation during an
immunologicalresponse[20].Asisincreasinglybeingunder-
stood, the development of allergic immunological responses
may be determined by innate host defence responses after
initial exposure to pathogens, allergens, or other irritants
[21–23]. These lead to local generation of cytokines that
stimulate DC, with eﬀects including upregulation of the
expression of costimulatory molecules such as CD40, CD80,
CD86, Jagged-1, and OX40L, as well as the production
of various chemokines (Figure 1)[ 24–27]. Such molecules
collectively function as “instructive” signals that drive initial
Th2 polarisation. The subsequent maintenance of the Th2
bias of the CD4+ T cells may be dependent on epigenetic
changes [28, 29], which is now a focus of considerable
interest in the study of the pathogenesis of asthma [30, 31].
Keyfactorsthatmayactivateand/ordrivethematuration
of conventional or myeloid DC, to promote Th2-biased dif-
ferentiation of CD4+ T-lymphocytes, include the cytokines
granulocyte-macrophage colony-stimulating factor (GM-
CSF), thymic stromal lymphopoietin (TSLP), interleukin
(IL)-25 and IL-33 [32]. Because airway epithelial cells (AEC)
can secrete GM-CSF, TSLP, IL-25, and IL-33 in response to
injury, as well as chemoattractants for DC such as CCL20,
the airway epithelium appears likely to play a critical role in
promoting recruitment/survival of DC and Th2 polarisation
of the immune response (Figure 1)[ 33–35].
2.1. Role of TSLP. Accumulating evidence indicates that
TSLP activates DC to prime CD4+ T cells for inﬂammatory
Th2 diﬀerentiation [36]. In the context of the induction
of childhood asthma, a role for AEC-derived TSLP in the
induction phase is strongly supported by in vitro studies.
Following exposure to DEP in vitro, human AEC generated
reactive oxygen species (ROS) and secreted TSLP, which
caused DC precursors to enhance expression of OX40L
and Jagged-1, which in turn promoted upregulation of
Th2 responses [37, 38]. Similarly, AEC exposed to double-
stranded RNA or infected with RV or RSV in vitro exhib-
ited marked upregulation of expression of TSLP [39, 40].
In vivo, transgenic overexpression of TSLP in the lungs
promoted an antigen-driven allergic inﬂammatory response
[41]. Injury by proteases has also been shown to elicit
generation of ROS by epithelial cells, leading to oxidation
of lipids, signalling through Toll-like receptor (TLR) 4, and
the production of TSLP that drives Th2 responses following
subcutaneous immunisation [42]. Because many allergens
exhibit endogenous protease activity, it is therefore also
possible that inhaled allergens might themselves contribute
to enhanced expression of TSLP by AEC.
To date, however, there are no reported in vitro studies
usingAECisolatedfromchildrennorhavetherebeenstudies
ontheroleofTSLPinananimalmodelofchildhoodasthma.
Further support for a role for TSLP in the development
of asthma comes from studies associating single nucleotide
polymorphismsintheTSLP geneoritspromoterregionwith
anincreasedriskofdeveloping asthmainchildhood[43,44].
2.2. Role of IL-25. Epithelial cell-derived IL-25 is increas-
ingly recognised as being important in the induction of
allergicinﬂammation[45].TSLP-activatedDCinducestrong
upregulation of the receptor for IL-25 on Th2 cells, thus
linking these two cytokine pathways [46]. Recent studies
have identiﬁed novel populations of cells involved in the
innate host response, which contribute to maintaining and
enhancing the Th2-biased response by secreting cytokines
such as IL-5 and IL-13 in response to IL-25 [47].
We have shown that IL-25 produced by AEC plays a key
role in the induction of a Th2-biased inﬂammatory response
following respiratory viral infection [35]. Furthermore, we
have recently provided convincing evidence that IL-25 is
of crucial importance in the induction phase of childhood
asthma. For the latter studies, we used a novel animal
model of neonatal infection with pneumonia virus of mice
(PVM), a species-speciﬁc paramyxovirus which simulates
RSV infection in human infants [48]. Following subsequent
intranasal sensitisation with ovalbumin and long-term low-
level challenge, these mice developed inﬂammation and
remodelling typical of chronic asthma, together with a Th2-
biased immunological response [49]. By themselves, neither
infection nor allergen exposure led to the development of
an asthmatic phenotype. This model therefore simulates the
interaction between early childhood infection with RSV and
sensitisation to inhaled allergens during the development of
childhood asthma.
In this model, we found that there was signiﬁcant upreg-
ulation of expression of IL-25 following neonatal infection
with PVM. Therefore, we tested the eﬀects of administration
ofaneutralisingantibodytoIL-25onthedevelopmentofthe
asthmatic phenotype, in comparison to administration of an
antibody to IL-4, which has long been recognised as having
a crucial role in the induction of Th2 responses [50]. Anti-
IL-25, administered either during chronic challenge or inJournal of Allergy 3
Environmental irritants
(infections, air pollutants,
ingested chemicals)
Oxidative stress of airway epithelium
Generation of reactive
oxygen species (ROS)
Direct toxicity
Upregulation of anti-
oxidant enzymes
(e.g., HO-1, GST-P1 via
Nrf2-ARE pathway)
Production of
cytokines/chemokines
(e.g., TSLP, IL-25,
IL-33, CCL20)
Recruitment, polarisation,
and expansion of Th2 cells
Recruitment, activation,
and maturation of DCs
(e.g., expression of CD40, CD86,
MHC II, Jagged-1, OX40L)
Activation of pattern
recognition receptors
(e.g., TLRs, NLRs, PARs)
Activation of intracellular
signalling pathways
(e.g., MAPKs, NF-κB)
Activation of innate
helper cells
(e.g., expression of IL-5, IL-13)
Figure 1: Environmental irritants may activate various pattern recognition receptors on AEC or may be directly toxic to the cells. Exposure
to such irritants frequently causes oxidant injury to AEC, leading to generation of reactive oxygen species and upregulation of antioxidant
enzyme systems. In parallel, intracellular signalling pathways are activated, triggering production of cytokines that can recruit and stimulate
DC, upregulate their expression of costimulatory molecules and promote Th2 polarisation of the CD4+ T-cell response. These cytokines
may also activate various populations of innate helper cells, leading to expansion of the Th2 cell population and helping to drive the allergic
inﬂammatory response.
early life alone, prevented key changes of airway remodelling
such as subepithelial ﬁbrosis and epithelial hypertrophy, and
suppressed development of a Th2 response. Anti-IL-4 was
more eﬀective in inhibiting allergic inﬂammation, prevented
goblet cell change but not other features of remodelling,
and also suppressed development of a Th2 response [51].
ThesenovelﬁndingssuggestthatblockinginductionofaTh2
response during the neonatal period or later in childhood
could be eﬀective for primary prevention of asthma, and that
IL-25 might play a crucial role in this process.
2.3. Role of Other Factors. GM-CSF clearly plays a key role
in the development of DC [52] and diﬀerentiated human
respiratoryepithelialcellsreleasesigniﬁcantamountsofGM-
CSF when exposed to DEP in vitro [53]. However, there is
currently no direct evidence of a role for GM-CSF produced
by AEC during the induction phase of childhood asthma.
There has been much speculation about the possible
contribution of IL-33 to the development of asthma, given
the capacity of this cytokine to promote DC maturation
towards a Th2-inducing phenotype in vitro [54]. While IL-
33isexpressedbyairwayepitheliuminasthmatics[55],there
is once again a paucity of direct evidence for a role in the
induction phase of allergic asthma.
3.TriggeringCytokineRelease by Airway
Epithelial Cells
There is now considerable evidence that an important
mechanism by which environmental irritants cause injury
to AEC is via inducing the production of reactive oxygen
species(ROS).Thishasbeenwellstudiedinvitroinresponse
t oi n j u r yb yR S V[ 56, 57]. Furthermore, activation of
antioxidant defence mechanisms, through binding of the
transcription factor Nrf2 to antioxidant response elements
(AREs), has been shown to be an important part of the
host response to RSV infection in vivo. RSV infection
caused induction of various ARE-driven enzymes, and gene-
targeted mice deﬁcient in Nrf2 had signiﬁcantly lower levels
of reduced glutathione in the lungs, higher levels of oxidative
modiﬁcation of lung proteins and lipids, and developed
signiﬁcantly more severe RSV disease, both in terms of
inﬂammation and epithelial injury [58]. Similarly, in vitro
studies have demonstrated that DEP induce oxidative stress,
with greater eﬀects on AEC than on other target cells such as
pulmonary macrophages [59]. There is clear evidence that
paracetamol (acetaminophen) decreases intracellular levels
ofreducedglutathioneandthuspredisposestoinjurybyROS
[60].4 Journal of Allergy
Oxidative stress leads to activation of key intracellular
signalling mechanisms, for example, the mitogen-activated
protein kinase (MAPK) and NF-κB pathways, and these
can be inhibited by administration of antioxidants [61, 62].
Activation in turn leads to the generation of chemoat-
tractants and proinﬂammatory cytokines. Whether similar
events occur in vivo during the induction phase of paediatric
asthma has not been formally demonstrated. However, the
concept that oxidant injury may be a key early event is
supported by evidence that functional polymorphisms in
oxidant defence genes increase the risk of developing asthma
in childhood [63, 64].
Environmental irritants may also trigger AEC via pattern
recognition receptors, including the predominantly cell
surface or endosomal TLRs and the cytoplasmic Nod-
like receptors (NLRs). These receptors are key components
of host innate defences, capable of recognising conserved
molecularpatternsassociatedwithpathogensorwithcellular
damage [65]. TLRs signal via adaptor proteins, notably
MyD88,leading toactivation ofMAPKandNF-κB signalling
pathways [66]. Whether TLR-dependent signalling pro-
motes the development of a Th2-biased response following
exposure to viral infection or environmental irritants is
not altogether clear. However, the potential importance
of TLR-mediated responses is supported by evidence that
polymorphisms in genes for TLR2 and TLR4 are related
to increased prevalence of asthma from birth up to the
age of 8 years [67]. Members of the NLR family assemble
into large multiprotein complexes, termed inﬂammasomes,
which activate caspase-1, a proteolytic enzyme that cleaves
and thus activates cytokines such as IL-1β and IL-18 for
secretion [65]. Expression of NLRs has been demonstrated
in the airway epithelium [68], but their role in the response
to injury by environmental irritants, or in driving allergic
inﬂammation, has not hitherto been investigated.
Another potentially important mechanism by which
cytokine release from AEC might be triggered is via the
enzymatic activity of some allergens on protease-activated
receptors. For example, fungal antigens appear to be able to
elicit secretion of TSLP via PAR-2 activation [69].
4. A ProasthmaticEpithelialPhenotype
An intriguing question, especially in relation to early-life
viral infection, is whether environmental injury might lead
to induction of a relatively stable epithelial phenotype
that characterises and/or promotes the development of
asthma [70]. There is no doubt that the airway epithelium
of asthmatics is diﬀerent to that of nonasthmatics, with
evidence of abnormal proliferation/repair and enhanced
production of proinﬂammatory cytokines [71–73]. Notably,
this includes enhanced expression of TSLP and GM-CSF by
asthmatic AEC [74, 75]. Furthermore, impaired production
of interferons has been related to the increased susceptibility
of asthmatics to viral infections [76, 77]. However, what
is not clear is whether this is a reason for development
of asthma, or an eﬀect of a predisposing factor or of
asthma itself. The issue is relevant to the ongoing debate
about the relationship between viral infection and asthma
[78]. Interestingly, recent evidence suggests that in a Th2-
biasedenvironment,whichinducesIL-13-drivenmucouscell
change in the airway epithelium, the altered epithelial lining
may be more susceptible to infection by rhinovirus [79].
Thus, the mucous cell hyperplasia and other remodelling of
the airway epithelium associated with the development of
childhood asthma [80] may predispose to progression of the
asthmatic phenotype, by promoting a vicious cycle of viral
and allergic inﬂammation.
5. Conclusion
Injury to AEC by environmental factors may have an
important role in initiating a cascade of responses that can
lead to the development of asthma in childhood. Oxidant
stress by environmental injurious agents may activate a
variety of intracellular signalling pathways, that in turn drive
the synthesis and secretion of multiple cytokines able to
promote the recruitment of T cells and their polarisation
towards a Th2 cytokine-secreting phenotype. However, at
present there are many gaps in our understanding of
the pathogenetic sequence of events. Further studies in
animal models of childhood asthma may help to identify
interventions that could reduce the risk of allergic asthma.
Caution is warranted, however, because the mechanisms
are likely to be complex and targeting single cytokines or
regulatory pathways is rarely successful in asthma [81, 82].
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